• AXIS Clinicals successfully completes 20th US FDA audit (April 2017)
  • AXIS Clinicals successfully completes 8th ANVISA – Brazil audit (August 2017)
  • AXIS Clinicals successfully completes MCC South Africa audit (March 2017)
  • AXIS Clinicals successfully completes GCC audit (February 2016)
  • AXIS Clinicals successfully completes 7th ANVISA – Brazil audit (March 2015)
  • AXIS Clinicals successfully completes WHO audit (March 2015)
  • AXIS Clinicals successfully completes 3rd MHRA audit (Sep 2014)
  • BA-BE studies conducted at AXIS Clinicals are accepted by Chile – ISP

Contact Us

 

India
Abhijit Chaudhari
AXIS Clinicals Limited 
1-121/1, Survey No.66 (Part) & 67(Part), 
Miyapur, Serilingampally,
Hyderabad  500049, India
Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.


Mexico
Sagar Sarode
AXIS Clinicals Latina.
Ing. Basiliso Romo Anguiano, 
225 Col. Gpe. Insurgentes, Del. G.A. Madero; C.P. 07870,
México D.F., MÉXICO
Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Business Enquiry Form

Fact sheet

  • 2,600+ clinical studies completed since inception
  • 350+ bioanalytical methods developed
  • 50+ successful Regulatory audits
  • Global footprint of operations with sites in India, U.S & Mexico.
  • Two clinical facilities (Hyderabad & Ahmedabad) in India
  • 100+ National and International Pharma/Biotech Sponsor companies working with AXIS
  • US FDA : 500+ approvals, EMEA : 100+ approvals, Canada : 50+ approvals, Australia : 50+ approvals
  • 500+ experienced employees working globally
  • Huge database of patient population in various therapeutic areas viz. Cardiology, Opthalmology, Schizophrenia, Diabetology, Oncology. Orthopedics etc..

Copyright Axis Clinicals - All Rights Reserved